A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

Clinical trial NCT05494593 · WITHDRAWN

Trial details

NCT number: NCT05494593
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Mucopolysaccharidosis (MPS)Hunter Syndrome

Start date: 2023-02-28
Primary completion: 2025-08-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.